Similar Posts
Canopy Growth Stock: Can It Sustain Recent Gains?
CGC Canopy Growth $6.88 +0.08 (+1.18%) (As of 11:14 AM ET) 52-Week Range $2.76 ▼ $19.20 Price Target $4.53 Canopy Growth NASDAQ: CGC is one of the North American players in the cannabis industry. The company’s shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated. The company’s value reached nearly…
Part 2: Current State of the Housing Market; Overview for mid-November 2025
by Calculated Risk on 11/13/2025 08:22:00 AM Today, in the Calculated Risk Real Estate Newsletter: Part 2: Current State of the Housing Market; Overview for mid-November 2025 A brief excerpt: Yesterday, in Part 1: Current State of the Housing Market; Overview for mid-November 2025 I reviewed home inventory and sales. I noted that the key…
The 1 TSX Stock Built for Trade-Headline Chaos
Trade headlines have felt like a pinball machine lately. Tariff threats pop up, markets flinch, then lawmakers scramble to tweak the rules, and the cycle starts again. In early February, the U.S. House votes kept legal and legislative challenges to U.S. tariffs on Canada in play, which tells you policy risk is not settled. Canada…
India–UK Trade Deal Expected to Begin by H1 2026: UK Envoy
January 2, 2026January 2, 2026 India and the UK are gearing up for a major trade milestone, with the Comprehensive Economic and Trade Agreement (CETA). It is expected to be implemented in the first half of 2026, according to British Deputy High Commissioner Andrew Fleming. The pact, signed on…
Singapore REITs Monthly Update (November 10th, 2024) – My Stocks Investing
FTSE ST Real Estate Investment Trusts (FTSE ST REIT Index) decreased from 700.03 to 649.94 (-7.15%) compared to last month’s update. Singapore REITs is currently going through a correction, moving towards a support zone at about 630-640. Short-term direction: Down Medium-term direction: Down Long-term direction: Sideways Immediate Support: Blue Support Line Immediate Resistance: 200D…
Lexeo Therapeutics (NASDAQ:LXEO) Insider Sells $34,758.72 in Stock
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) insider Tai Sandi See sold 3,888 shares of the stock in a transaction dated Friday, October 17th. The stock was sold at an average price of $8.94, for a total transaction of $34,758.72. Following the sale, the insider owned 65,862 shares of the company’s stock, valued at…
